- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03551977
The Norwegian "iCanCope With Pain" App
Cultural Adaptation and Evaluation of the "iCanCope With Pain" App Among Norwegian Adolescents Living With Pain
Background: Research evidence shows that prevalence of pain in adolescents is increasing and is therefore recognized as a growing health problem. Psychological interventions delivered remotely through the internet may reduce intensity or severity of pain among children and adolescents with chronic pain. The iCanCope with Pain program is an existing web- and mobile-based self-management program, which is developed as a multi-center study funded by the Canadian Institutes of Health Research and is based on identified health care needs and current best practices for pain self-management.
Objectives: The primary objectives are to describe the translation and cultural adaptation of the Norwegian version of the iCanCope with Pain mobile application and evaluate the effect in an upcoming randomized controlled trail with adolescents with chronic pain.
Study sample: 16-19-year-old adolescents with self-declared persistent and/or chronic pain. Recruited from high schools in Southern Norway.
Theoretical framework: Cognitive behavioral therapy (CBT) is explained by an integration of behavioral and cognitive theories of human behavior and psychopathology and is often the preferred treatment of choice for adolescents with different health disorders. The theoretical framework of CBT is integrated in the iCanCope with Pain app in terms of five components. The intervention group will receive the app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education. The control group will receive the app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function.
Methods: Both qualitative and quantitative data will be gathered for evaluating the Norwegian version of the iCanCope with Pain app. Usability testing are assessed in both laboratory settings and in field using observation, interviews and questionnaires, which provide necessary information for an upcoming randomized controlled trail (RCT). Outcomes will in the RCT be measured at baseline (mid-April) and after an 8 weeks intervention (mid-June).
The study is part of a PhD project.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Kristiansand, Norwegen, 4633
- Erik Grasaas
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- 16-19-year-old adolescents
- with persistent and/or chronic pain, weekly suffered and lasting 3 months or more based on subjective reporting
- be able to read and understand Norwegian
- have their own smartphone.
Exclusion Criteria:
- Adolescents with cognitive disability or diseases, because of the risk of not correctly understanding the iCanCope with Pain program via self-report, goal setting and/or library reading.
- Adolescents that have participated in the usability testing of the Norwegian iCanCope with Pain app
- Adolescents with diagnoses from a pathological or medical origin (e.g hematology/oncology patients) will also be excluded because the program was not specifically designed for these pain groups.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Intervention group
The intervention group will receive the iCanCope with Pain app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education
|
The participants are free to use the Norwegian iCanCope with Pain app as much as they want during the 8 week intervention period.
The only support available is technical support.
|
Aktiver Komparator: Control group
The control group will receive the iCanCope with Pain control app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function.
|
The participants are free to use the Norwegian iCanCope with Pain control app as much as they want during the 8 week intervention period.
The only support available is technical support.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Attrition rate
Zeitfenster: Baseline and 8-weeks
|
Change in participants completed the post-questionnaire divided by the number of participants at baseline.
|
Baseline and 8-weeks
|
App engagement
Zeitfenster: Baseline to 8 weeks.
|
Completion of daily symptom check-ins was used as a proxy for app engagement.
|
Baseline to 8 weeks.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Physical activity
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of the International Physical Activity Questionnaire (IPAQ).
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Coping
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of the General Self-Efficacy Questionnaire Short Version (GSEQ).
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Social participation
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of school absence (General Information Questionnaire).
Lower values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Over-The-Counter (OTC) analgesics
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of OTC analgesics consumption (General Information Questionnaire).
Lower values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Perceived social support from friends
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Perceived Social Support from friends Questionnaire (PSS).
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Pain self-efficacy questionnaire
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Pain Self-Efficacy Questionnaire (PSEQ).
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Anxiety and depression
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Hospital Anxiety and Depression Scale Questionnaire (HADS).
Lower values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Global impression of change
Zeitfenster: After 8 weeks (post-intervention)
|
Change in Patients' Global Impression of Change Scale (PGIC) from 1-7.
Higher values at post-intervention represent a better outcome.
|
After 8 weeks (post-intervention)
|
Health-related quality of life (HRQOL)
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Kidscreen 52 Questionnaire.
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Pain experience
Zeitfenster: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Lubeck Pain Questionnaire (LPQ).
Lower values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Kristin Haraldstad, PhD, UiA
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Grasaas E, Helseth S, Fegran L, Stinson J, Smastuen M, Lalloo C, Haraldstad K. App-based intervention among adolescents with persistent pain: a pilot feasibility randomized controlled trial. Pilot Feasibility Stud. 2022 Jul 27;8(1):158. doi: 10.1186/s40814-022-01113-0.
- Grasaas E, Helseth S, Fegran L, Stinson J, Smastuen M, Haraldstad K. Health-related quality of life in adolescents with persistent pain and the mediating role of self-efficacy: a cross-sectional study. Health Qual Life Outcomes. 2020 Jan 30;18(1):19. doi: 10.1186/s12955-020-1273-z.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 1310 63221
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Schmerzen
-
Foundation IRCCS San Matteo HospitalAktiv, nicht rekrutierendGreater Trochanteric Pain Syndrome beider unteren ExtremitätenItalien
-
Gazi UniversityAbgeschlossenGesäß-Tendinitis | Greater Trochanteric Pain Syndrome beider unteren ExtremitätenTruthahn
-
Lawson Health Research InstituteNoch keine RekrutierungSchmerzen im unteren Rücken | Greater Trochanteric Pain Syndrome
-
C.R.Darnall Army Medical CenterUnbekanntGreater Trochanteric Pain SyndromeVereinigte Staaten
-
Guna S.p.aBeendetGreater Trochanteric Pain Syndrome | Pertrochantäre Fraktur | Gesäß-Tendinitis | GTPS - Greater Trochanteric Pain Syndrome | Sehnenerkrankung | GesäßmuskulaturItalien
-
Smith & Nephew, Inc.AbgeschlossenHüftschmerzen chronisch | Greater Trochanteric Pain SyndromeAustralien
-
NHS Greater Glasgow and ClydeNHS Research ScotlandRekrutierungGreater Trochanteric Pain SyndromeVereinigtes Königreich
-
Kutahya Health Sciences UniversityRekrutierungGreater Trochanteric Pain SyndromeTruthahn
-
Massachusetts General HospitalAbgeschlossenGreater Trochanteric Pain SyndromeVereinigte Staaten
-
Montefiore Medical CenterNoch keine RekrutierungGreater Trochanteric Pain SyndromeVereinigte Staaten
Klinische Studien zur iCanCope with Pain
-
UNC Lineberger Comprehensive Cancer CenterAbgeschlossenBrustkrebs | Physische Aktivität | AlternVereinigte Staaten
-
Stanford UniversityAktiv, nicht rekrutierendResilienz, Psych | Tragbare Geräte | Psychologisches Wohlbefinden | Persönliche und berufliche Erfüllung | MultiomikVereinigte Staaten
-
Hasselt UniversityAbgeschlossenMultiple SkleroseBelgien
-
University of ManitobaCancerCare ManitobaAktiv, nicht rekrutierendKrebs | Kognitive Beeinträchtigung | Kognitive Dysfunktion | Jugendliche | Junge ErwachseneKanada
-
Teesside UniversityConnect Health LtdAbgeschlossen
-
University of North Carolina, Chapel HillAbgeschlossenArthrose | Stürze, Unfall
-
The Hong Kong Polytechnic UniversityAbgeschlossenGerät unwirksamHongkong
-
Talita Cumi Ltd.Noch keine RekrutierungMuskel-Skelett-Schmerzen | Angst vorm fallenVereinigtes Königreich
-
University of FloridaAgency for Healthcare Research and Quality (AHRQ)Noch keine RekrutierungMuskel-Skelett-Schmerzen | Chronischer Schmerz | Opioidgebrauch
-
Pfizer's Upjohn has merged with Mylan to form Viatris...AbgeschlossenNeuralgie | Neuropathischer Schmerz | Nervenschmerzen